Company Filing History:
3 out of 179 
1 out of 2,893 
Years Active: 2018-2025
Title: Chandrasekhar Abbineni: Innovator in Pharmaceutical Chemistry
Introduction
Chandrasekhar Abbineni is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 5 patents to his name, Abbineni's work is paving the way for advancements in medical treatments.
Latest Patents
Abbineni's latest patents include innovative compounds that target specific biological pathways. One of his notable inventions is the development of pyridazine derivatives as SMARCA2/4 degraders. This invention provides pyridazine derivatives of formula (I), which are therapeutically useful in the treatment and/or prevention of diseases or disorders dependent upon SMARCA2/4 in mammals. The invention also details the preparation of these compounds and pharmaceutical compositions comprising at least one of the pyridazine derivatives or a pharmaceutically acceptable salt, or a stereoisomer thereof. Another significant patent involves small molecule inhibitors of TEAD transcription factors. These compounds inhibit the activity of the TEAD transcription factor and are useful in treating diseases related to its activity, including cancer and other disorders.
Career Highlights
Throughout his career, Abbineni has worked with reputable organizations, including Orion Corporation and The General Hospital Corporation. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in pharmaceutical development.
Collaborations
Abbineni has collaborated with several professionals in his field, including Susanta Samajdar and Sanjita Sasmal. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Chandrasekhar Abbineni is a distinguished inventor whose work in pharmaceutical chemistry is making a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical science.